PHARMABRAIN Trademark

Trademark Overview


On Tuesday, November 21, 2023, a trademark application was filed for PHARMABRAIN with the United States Patent and Trademark Office. The USPTO has given the PHARMABRAIN trademark a serial number of 79385537. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 12, 2024. This trademark is owned by PHARMABRAIN GmbH. The PHARMABRAIN trademark is filed in the Education & Entertainment Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Business training consultancy; training and further training consultancy in the fields of pharmacology, medical and pharmaceutical communication; education consultancy; vocational guidance; educational services, namely, providing e-learning training and further training in the fields of pharmacology, medical and pharmaceutical communication; arranging and conducting of seminars in the fields of pharmacology, medical and pharmaceutical communication; arranging and conducting of workshops in the fields of pharmacology, medical and pharmaceutical communication; education in the fields of pharmacology, medical and pharmaceutical communication rendered through correspondence courses

Pharmaceutical advisory services

Computer system analysis services; computer software design; technical consultancy in the field of information technology
pharmabrain

General Information


Serial Number79385537
Word MarkPHARMABRAIN
Filing DateTuesday, November 21, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, November 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 12, 2024

Trademark Statements


Goods and ServicesBusiness training consultancy; training and further training consultancy in the fields of pharmacology, medical and pharmaceutical communication; education consultancy; vocational guidance; educational services, namely, providing e-learning training and further training in the fields of pharmacology, medical and pharmaceutical communication; arranging and conducting of seminars in the fields of pharmacology, medical and pharmaceutical communication; arranging and conducting of workshops in the fields of pharmacology, medical and pharmaceutical communication; education in the fields of pharmacology, medical and pharmaceutical communication rendered through correspondence courses
Description of MarkThe mark consists of the following: the stylized wording PHARMABRAIN where PHARMA appears in red and BRAIN appears in black and the letter I in BRAIN forms a vertical arch with a bulge on the left side and a black dot above it; above the letters RAIN appears a semi-enclosed circle outline comprised of four segments being from left to right, red, orange-red, light orange, and light pink; within this semi-enclosed circle appears a smaller pink oval design outline having an opening in the outline at the upper right corner; the two circular and oval designs are formed as to resemble a stylized brain.
Indication of Colors claimedThe color(s) red, orange-red, black, light orange, light pink and pink is/are claimed as a feature of the mark.
Goods and ServicesPharmaceutical advisory services
Goods and ServicesComputer system analysis services; computer software design; technical consultancy in the field of information technology

Classification Information


International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateFriday, December 15, 2023
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 15, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, December 15, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePHARMABRAIN GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE

Party NamePHARMABRAIN GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events


Event DateEvent Description
Thursday, December 14, 2023SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
Friday, December 15, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 19, 2023APPLICATION FILING RECEIPT MAILED
Monday, June 24, 2024ASSIGNED TO EXAMINER
Tuesday, June 25, 2024NON-FINAL ACTION WRITTEN
Wednesday, June 26, 2024NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, July 18, 2024NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, July 18, 2024REFUSAL PROCESSED BY MPU
Friday, September 6, 2024NEW REPRESENTATIVE AT IB RECEIVED
Saturday, September 14, 2024REFUSAL PROCESSED BY IB
Wednesday, September 25, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 25, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 25, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, October 2, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, October 2, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, October 2, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 2, 2024EXAMINERS AMENDMENT -WRITTEN
Wednesday, October 2, 2024EXAMINERS AMENDMENT E-MAILED
Wednesday, October 23, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 12, 2024PUBLISHED FOR OPPOSITION
Tuesday, November 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED